Disc up another 5.4% last night on impressive volume to a market cap of $2.5 Billion AUD. That is more than three times the valuation of CUV. CUV has the FDA, EMA drug and the absolute monopoly on EPP and great cash and profits with a Phase 3 into blockbuster Vitiligo. Loss making Disc just hoping to one day in many years to achieve approval in EPP and enter that market. I think it's fair to say shorters have had a big impact here at CUV as ASIC daily data shows and some effort needs to be made to protect shareholder interests right now via a share buyback. Disc is also so much better at attracting investor interest than at CUV and they need to lift their game a lot in that area - after all the newsletter stated it only took one institution buying a lot of shares in one month to take the CUV price over $40.
All IMO DYOR
Disc up another 5.4% last night on impressive volume to a market...
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.39 |
Change
0.430(2.87%) |
Mkt cap ! $771.0M | |||
| Open | High | Low | Value | Volume |
| $14.96 | $15.39 | $14.83 | $2.149M | 141.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 590 | $15.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.41 | 1079 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| CUV (ASX) Chart |